162 related articles for article (PubMed ID: 28331027)
21. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor.
Valdes-Socin H; Almanza MR; Fernández-Ladreda MT; Daele DV; Polus M; Chavez M; Beckers A
Arch Endocrinol Metab; 2017; 61(5):506-509. PubMed ID: 28977163
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia.
Papazachariou IM; Virlos IT; Williamson RC
HPB (Oxford); 2001; 3(3):221-5. PubMed ID: 18333019
[TBL] [Abstract][Full Text] [Related]
23. Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.
Haemels M; Delaunoit T; Van Laere K; Van Cutsem E; Verslype C; Deroose CM
BMC Gastroenterol; 2020 Oct; 20(1):324. PubMed ID: 33008295
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
Pitts S; Mahipal A; Bajor D; Mohamed A
Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
Thompson JT; Paschold EH; Levine EA
Am Surg; 2001 Jun; 67(6):585-8. PubMed ID: 11409809
[TBL] [Abstract][Full Text] [Related]
26. Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemia.
Ratcliffe WA; Bowden SJ; Dunne FP; Hughes S; Emly JF; Baker JT; Pye JK; Williams CP
Clin Endocrinol (Oxf); 1994 May; 40(5):679-86. PubMed ID: 8013148
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
28. Value of assessing parathyroid hormone-like activity in a case of extreme hypercalcaemia.
Ranganath L; Jamal H; Jones L; Goddard PF
J Clin Pathol; 1998 Mar; 51(3):257-8. PubMed ID: 9659276
[TBL] [Abstract][Full Text] [Related]
29. Case report: lanreotide in the management of hypercalcemia of malignancy.
Anthony LB; May ME; Oates JA
Am J Med Sci; 1995 Jun; 309(6):312-4. PubMed ID: 7771500
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia as the first finding of late recurrence of a PTHrP neuroendocrine tumor of the pancreas.
Febrero B; Gómez B; Ruiz-Manzanera JJ; Ros-Madrid I; Rodríguez JM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):31-32. PubMed ID: 38350837
[No Abstract] [Full Text] [Related]
31. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
32. A Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor.
Quinn CD; Chaudhary F; Gould-Simon A; Chen B; Bhandal HS; Chaudhary U
Am J Case Rep; 2022 Jul; 23():e935783. PubMed ID: 35849548
[TBL] [Abstract][Full Text] [Related]
33. [Unusual cause of hypercalcemia in pregnancy].
Mehl L; Schrader J; Winterberg T; Daniels T; Gross A; Weidner U; Clauditz TS; Lock G
Z Gastroenterol; 2021 Feb; 59(2):143-148. PubMed ID: 33556973
[TBL] [Abstract][Full Text] [Related]
34. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
35. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
36. Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.
Karuppiah D; Thanabalasingham G; Shine B; Wang LM; Sadler GP; Karavitaki N; Grossman AB
Eur J Endocrinol; 2014 Jul; 171(1):K1-5. PubMed ID: 24743399
[TBL] [Abstract][Full Text] [Related]
37. Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide.
van Raalte DH; Goorden SM; Kemper EA; Brosens LA; ten Kate RW
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26160550
[TBL] [Abstract][Full Text] [Related]
38. Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
Barakat MT; Ashrafian H; Todd JF; Meeran K; Williams GR
Lancet Oncol; 2004 Oct; 5(10):633-5. PubMed ID: 15465467
[No Abstract] [Full Text] [Related]
39. Pancreatic endocrine carcinoma with ectopic PTH-production and paraneoplastic hypercalcaemia.
Arps H; Dietel M; Schulz A; Janzarik H; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1986; 408(5):497-503. PubMed ID: 3082066
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic neuroendocrine tumor associated with humoral hypercalcemia of malignancy and carcinoid tumor: a case report and review of the literature.
Shah RH; Martinez D
Pancreas; 2013 Apr; 42(3):549-51. PubMed ID: 23211368
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
